You just read:

PTC Therapeutics Provides Update on Health Canada Review of Translarna™ (ataluren) for the Treatment of Duchenne Muscular Dystrophy

News provided by

PTC Therapeutics, Inc.

Mar 14, 2016, 08:00 ET